Here’s some exciting news. The doctors and researchers at Seattle Children’s are about to launch a new, pioneering clinical therapy trial that uses T-Cells to target tumors in children. This is the type of research we are going to help fund and that we believe will make a huge difference in the fight against pediatric cancer.

You can read more about this trial – and T-Cell Immunotherapy – on Seattle Children’s website:

​​https://pulse.seattlechildrens.org/seattle-childrens-launches-pioneering-immunotherapy-clinical-trial-targeting-four-antigens-at-the-same-time-to-combat-pediatric-brain-and-spinal-cord-tumors/